Please provide your email address to receive an email when new articles are posted on . For older patients who initiated hemodialysis without permanent access, those with arteriovenous fistula ...
Neither omega-3 fatty acids from fish nor aspirin prevented failure of arteriovenous fistulae (AVFs) in patients receiving hemodialysis, according to results of a new study published online January 3 ...
Please provide your email address to receive an email when new articles are posted on . Researchers from Canada found placement of an arteriovenous fistula slowed decline in kidney function for ...
Interim Phase 3 findings will be presented in a prestigious late-breaking oral session at the leading meeting for kidney health professionals. – ...
(HealthDay)—A proximal radial artery endovascular arteriovenous fistula to allow vascular access in patients who require hemodialysis remains highly functional at two years, according to a study ...
More than 600,000 people in the United States have end-stage kidney disease, and about 450,000 are kept alive through chronic hemodialysis to remove waste products from their blood. This requires ...
The first North American patients were treated by a multidisciplinary clinical team led by Dr. Mohamad Hussain and Dr. Dirk Hentschel. The AMPLIFI-1 Trial is designed to evaluate the safety and ...
In a trial, an acellular tissue engineered vessel had superior functional patency for hemodialysis with acceptable safety compared with an arteriovenous fistula in high-risk patients. An acellular ...
An investigational product called Acellular Tissue Engineered Vessel demonstrated superior hemodialysis vascular access outcomes compared with AVFs in a phase 3 trial. A bioengineered human tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results